Impel Pharmaceuticals Inc. (NASDAQ:IMPL) Sees Large Increase in Short Interest

Impel Pharmaceuticals Inc. (NASDAQ:IMPL – Get Rating) saw a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 389,700 shares, a growth of 17.1% from the March 31st total of 332,800 shares. Currently, 5.1% of the company’s shares are sold short. Based on an average […]

Related Keywords

United States , ,Nasdaq ,Impel Pharmaceuticals Inc ,Tower Research Capital ,Raymond James Associates ,Impel Pharmaceuticals Trading ,News Ratings For Impel Pharmaceuticals Daily ,Mcdonald Partners ,Institutional Investors Weigh In On Impel Pharmaceuticals ,Impel Pharmaceuticals ,Citadel Advisors ,Get Rating ,Street Group ,Research Capital ,Pharmaceuticals Inc ,Impel Pharmaceuticals Daily ,Nasdaq Impl ,Simpl ,Medical ,Stocks ,Options ,Put ,Call ,